ResearcherKansas City VA Medical CenterActive in the last 2 years
Amlan Kumar Das
Matched on ORCID iD 0000-0002-9295-3743; OpenAlex author ID A5056858363. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2018: 1 paper · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: 2 papers · 2024: 1 paper · 2025: 1 paper
Papers 6
- Retraction notice to “Porphyrins to restrict progression of pancreatic cancer by stabilizing KRAS G-quadruplex: In silico, in vitro and in vivo validation of a… Co-author DOI 10.1016/j.ejps.2025.107196↗
- Chronic pancreatitis as a driving factor for pancreatic cancer: An epidemiological understanding. Co-author DOI 10.5306/wjco.v15.i12.1459↗
- Emerging role of non-invasive and liquid biopsy biomarkers in pancreatic cancer. Co-author DOI 10.3748/wjg.v29.i15.2241↗
- Deoxyribonucleic acid methylation driven aberrations in pancreatic cancer-related pathways. First author DOI 10.4251/wjgo.v15.i9.1505↗
- CYR61/CCN1 Regulates dCK and CTGF and Causes Gemcitabine-resistant Phenotype in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/1535-7163.mct-18-0899↗
- Porphyrins to restrict progression of pancreatic cancer by stabilizing KRAS G-quadruplex: In silico, in vitro and in vivo validation of anticancer strategy. Co-author DOI 10.1016/j.ejps.2018.09.011↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Akash Bararia · 3 shared papers, 2023–2024 · strength 0.73
- Paper Chronic pancreatitis as a driving factor for pancreatic cancer: An epidemiological understanding. DOI 10.5306/wjco.v15.i12.1459↗
- Paper Deoxyribonucleic acid methylation driven aberrations in pancreatic cancer-related pathways. DOI 10.4251/wjgo.v15.i9.1505↗
- Paper Emerging role of non-invasive and liquid biopsy biomarkers in pancreatic cancer. DOI 10.3748/wjg.v29.i15.2241↗
- Nilabja Sikdar · 3 shared papers, 2023–2024 · strength 0.73
- Paper Chronic pancreatitis as a driving factor for pancreatic cancer: An epidemiological understanding. DOI 10.5306/wjco.v15.i12.1459↗
- Paper Deoxyribonucleic acid methylation driven aberrations in pancreatic cancer-related pathways. DOI 10.4251/wjgo.v15.i9.1505↗
- Paper Emerging role of non-invasive and liquid biopsy biomarkers in pancreatic cancer. DOI 10.3748/wjg.v29.i15.2241↗
- Rudradip Pattanayak · 2 shared papers, 2018–2025 · strength 0.34
- Paper Retraction notice to “Porphyrins to restrict progression of pancreatic cancer by stabilizing KRAS G-quadruplex: In sili… DOI 10.1016/j.ejps.2025.107196↗
- Paper Porphyrins to restrict progression of pancreatic cancer by stabilizing KRAS G-quadruplex: In silico, in vitro and in vi… DOI 10.1016/j.ejps.2018.09.011↗
- Maitree Bhattacharyya · 2 shared papers, 2018–2025 · strength 0.34
- Paper Retraction notice to “Porphyrins to restrict progression of pancreatic cancer by stabilizing KRAS G-quadruplex: In sili… DOI 10.1016/j.ejps.2025.107196↗
- Paper Porphyrins to restrict progression of pancreatic cancer by stabilizing KRAS G-quadruplex: In silico, in vitro and in vi… DOI 10.1016/j.ejps.2018.09.011↗
- Sudeep Banerjee · 1 shared paper, 2023 · strength 0.22
- Gargi Maity · 1 shared paper, 2019 · strength 0.08
- Sanku Mallik · 1 shared paper, 2019 · strength 0.08
- Sushanta K. Banerjee · 1 shared paper, 2019 · strength 0.08
- Snigdha Banerjee · 1 shared paper, 2019 · strength 0.08
- Daniel D. Von Hoff · 1 shared paper, 2019 · strength 0.08
- Arnab Ghosh · 1 shared paper, 2019 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.